Refine by
Neurodegeneration Suppliers & Manufacturers
59 companies found
based inBoston, MASSACHUSETTS (USA)
Founded by Flagship Pioneering, Valo is a mission-driven technology company that was created with the belief that the drug discovery and development process can and should be better—faster, less expensive, and with a higher probability of success. ...
based inSherbrooke, QUEBEC (CANADA)
Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma ...
based inStockholm, SWEDEN
BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as disease modifiers. They ...
BioArctic has developed a technology platform that has proven to be successful when the company’s first drug candidate was developed, the antibody BAN2401 for Alzheimer´s disease. Our mission is to improve quality of life for patients ...
based inProvidence, RHODE ISLAND (USA)
A spinout of Oxford University, founded by a global team of experienced entrepreneurs, technologists, and neuroscientists, ni2o is continuing the work started by MIT’s Mind Machine Project – developing a revolutionary brain-computer interface (BCI) ...
based inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
We are developing an anti-tau product candidate that has the potential to address multiple neurodegenerative conditions, including AD, by targeting abnormal tau proteins alone and in potential combination with other pathological proteins such as ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD® Blood Test Answers Calls from Patients, Advocates, and Healthcare Providers Who Want Earlier Answers. Summary of Test and Patient Selection. The PrecivityAD® test identifies whether a patient is likely to have the presence ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential spectroscopy to detect ...
based inWoburn, MASSACHUSETTS (USA)
As the scientific leader in the biological role of the microbiome gut-brain axis and its impact on neurological conditions, Axial Therapeutics is uniquely positioned to advance a fundamentally different therapeutic approach for the treatment of ...
based inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
Clinical grade human astrocytes (the nervous system supporting cells) for the treatment of ALS and other neurodegenerative diseases. Received approval by the Israeli Ministry of Health to commence our phase I/IIa clinical trial in ALS patients. 6 ...
based inNew York, NEW YORK (USA)
Altucell, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large 'unmet need' in cell, molecular and regenerative therapy for treatment of Diabetes and other autoimmune and ...
Microcapsules constitute immunoisolatory physical barriers that prevent immune rejection of the enveloped cells upon graft, while offering a special 3D Cell matrix like microenvironment (which greatly favors retention of cell viability and ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
NEUROLINCS : A non-invasive in-vitro diagnostic test measuring 7494 brain-enriched long non-coding RNAs (lncRNAs) that are specific to neurodegenerative ...
based inMissoula, MONTANA (USA)
FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...
based inChantilly, VIRGINIA (USA)
Arthus Biosystems is pleased to provide a series of research reagents and kits to help carry out scientific investigations related to methionine cycle, the critical biochemical pathway that is conserved throughout evolution in all organisms. Our SAM ...
S-adenosylmethionine (SAM) is an important molecule in methionine cycle pathway and one carbon metabolism pathway that are implicated in many metabolic abnomalities found in humans. Methylation index is defined as the ratio of SAM and SAH, which is ...
based inCAEN, FRANCE
Lys Therapeutics, first-in-class biotherapies against neurological diseases. Lys Therapeutics is a French biotech company developing innovative drugs to treat patients suffering from neurovascular or neurodegenerative disorders, including stroke and ...
Glunomab / Glunozumab®: a monoclonal antibody counteracting the strong toxicity triggered by the interaction of an endogenous protease, tissue plasminogen activator (tPA) with NMDA receptors ...
based inEncinitas, CALIFORNIA (USA)
Neurodigitech (NDT) is dedicated to 1) Neurohistological and neuropathological services of the central nervous system (CNS), 2) Neural staining kits, 3) High-throughput digital microscopic imaging and stereology-based quantitative morphology, and 4) ...
The NDT teams in specialized in both non-GLP and GLP compliant pre-clinical assessments of CNS disease therapeutics using a variety of biomarkers, including histology, immunohistochemical and histochemical methods. In particular, NDT is dedicated to ...
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier ...
based inSurprise, ARIZONA (USA)
Traditional technologies currently utilized for the diagnosis of Alzheimer's and Parkinson's disease are not sensitive enough to perform early detection and need central spinal fluid (CSF) samples from patients, which is invasive and painful. Our ...
Use Tau protein IMR Reagent only with the XacPro-S System (MagQu Co., Ltd.). The reagent is used to quantitatively measure Tau protein in human fluid specimen, such as plasma. Tau protein is a microtubule-associated protein and is abundant in ...
based inGranada, SPAIN
Neuron Bio develops and manages biosolutions and projects in the biotechnological field for their application in the pharmaceutical and oleochemical industry through its subsidiaries and its specialized areas. Its pharma division is mainly devoted ...
Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for ...
based inMagdeburg, GERMANY
HASOMED GmbH is an owner-managed family business. We grow from our own resources, independent of outside capital, 'with our feet on the ground'. The management acts in Christian responsibility. Committed employees are the most important capital of ...